---
$id: https://graph.org.ai/products/commodity/51172301
$type: Product
source: UNSPSC
code: "51172301"
title: "Deferoxamine"
class: "51172300"
classTitle: "Antidotes and emetics"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Deferoxamine

**UNSPSC Code**: 51172301
**Class**: [Antidotes and emetics](Antidotes and emetics.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a metal chelator with the molecular formula C25H48N6O8, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier J06Y7MXW4D, chemically known as 3,9,14,20,25-pentaazatriacontane-2,10,13,21,24-pentone, 30-amino-3,14,25-trihydroxy- but more generally known as deferoxamine, which bears U.S. National Institutes of Health Compound Identifier 2973. European Medicines Agency schedules Deferoxamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06942MIG. World Health Organization schedules deferoxamine in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary. DEFEROXAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

